FilingReader Intelligence
Fudan-Zhangjiang announces final dividend and structured deposit product
April 2, 2025 at 05:06 PM UTC•By FilingReader AI
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKEX: 1349) has announced a final dividend of RMB 0.03 per share for the year ended December 31, 2024, payable on August 25, 2025, to shareholders registered on July 17, 2025. The dividend, approved on June 26, 2025, will be distributed in HKD at HKD 0.0321 per share, based on an exchange rate of RMB 1: HKD 1.0689.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
HKEX:1349•Hong Kong Exchange
News Alerts
Get instant email alerts when Shanghai Fudan-Zhangjiang Bio-PharmaLtd publishes news
Free account required • Unsubscribe anytime